| S8141 |
Cl-amidine
|
Cl-amidine is an irreversible pan-peptidylarginine deiminase (PAD) inhibitor with IC50 values of 5.9 ± 0.3 μM, 0.8 ± 0.3 μM, 6.2 ± 1.0 μM for PAD4, PAD1 and PAD3, respectively. Cl-amidine induces apoptosis.
|
-
Immunity, 2025, S1074-7613(25)00069-X
-
Cell Rep, 2025, 44(2):115226
-
Nat Commun, 2024, 15(1):8663
|
|
| S1591 |
Bestatin (Ubenimex)
|
Bestatin (Ubenimex) is a potent aminopeptidase-B and leukotriene (LT) A4 hydrolase inhibitor, used in the treatment of acute myelocytic leukemia.
|
-
Cell Rep, 2024, 43(4):114041
-
iScience, 2024, 27(10):110862
-
Sci Rep, 2024, 14(1):12549
|
|
| S2286 |
Cyclosporin A
|
Cyclosporin A, a non-polar cyclic oligopeptide, is an immunosuppressive agent that binds to cyclophilin and then inhibits calcineurin with IC50 of 7 nM in a cell-free assay. Cyclosporin A is generally given following transplant surgery to prevent rejection and has been used to test its toxic effect on a perfused 3D proximal tubule model.Cyclosporin A (NSC 290193) can be used to induce animal models of Chronic Rejection of Liver Transplantation.
|
-
Signal Transduct Target Ther, 2025, 10(1):81
-
Signal Transduct Target Ther, 2025, 10(1):167
-
Adv Sci (Weinh), 2025, 12(36):e06150
|
|
| S8760 |
Iberdomide (CC-220)
|
Iberdomide (CC-220) is a novel oral immunomodulatory compound that targets cereblon, part of the CRL4CRBN E3 ubiquitin ligase complex, with an IC50 of 60 nM in a competitive TR-FRET assay. Iberdomide (CC-220) induces apoptosis with antitumor and immunostimulatory activities.
|
-
Cell Rep Med, 2025, S2666-3791(25)00102-8
-
J Med Virol, 2025, 97(8):e70537
-
Cancer Res, 2025, 10.1158/0008-5472.CAN-24-1136
|
|
| S1576 |
Sulfasalazine
|
Sulfasalazine is a sulfa derivative of mesalazine, used as an anti-inflammatory agent to treat bowel disease and rheumatoid arthritis. This compound is a potent and specific inhibitor of nuclear factor kappa B (NF-κB), TGF-β and COX-2. It induces ferroptosis, apoptosis and autophagy.
|
-
Med Oncol, 2024, 41(8):188
-
Adv Sci (Weinh), 2023, 10(20):e2300517
-
Proc Natl Acad Sci U S A, 2022, 119(36):e2117396119
|
|
| S5004 |
Pimecrolimus
|
Pimecrolimus (Elidel,ASM 981,SDZ-ASM 981) is an immunophilin ligand, which binds specifically to the cytosolic receptor, immunophilin macrophilin-12 (FKBP-12); a calcineurin inhibitor.
|
-
iScience, 2024, 27(10):110862
-
J Pers Med, 2022, 12(2)258
-
Hum Cell, 2022, 10.1007/s13577-022-00671-y
|
|
| S2910 |
Tempol
|
Tempol (4-Hydroxy-TEMPO) is a superoxide scavenger that displays neuroprotective, anti-inflammatory and analgesic effects. Phase 2.
|
-
Cell Death Dis, 2024, 15(10):760
-
Cell Signal, 2023, 108:110712
-
J Ginseng Res, 2023, 47(1):144-154
|
|
| S1439 |
Tranilast
|
Tranilast is an antiallergic drug by inhibiting lipid mediator and cytokine release from inflammatory cells, used for the treatment of allergic disorders such as asthma, allergic rhinitis and atopic dermatitis.
|
-
EMBO Mol Med, 2025, 17(4):747-774
-
Virol J, 2025, 22(1):301
-
PLoS One, 2025, 20(2):e0319381
|
|
| S3648 |
Amlexanox
|
Amlexanox is an anti-inflammatory antiallergic immunomodulator and also an inhibitor of the protein kinases TBK1 and IKK-ε.
|
-
Biomed Pharmacother, 2025, 186:117991
-
Cell Death Discov, 2025, 11(1):286
-
Sci Adv, 2025, 11(4):eadq2395
|
|
| S2359 |
Sinomenine
|
Sinomenine (Cucoline, Kukoline), a pure alkaloid extracted from the chinese medical plant Sinomenium acutum, is used for the treatment of rheumatism and arthritis.
|
-
BMC Pulm Med, 2024, 24(1):229
-
Sci Rep, 2023, 13(1):3933
-
Biomed Res Int, 2022, 2022:4914005
|
|